ATXS - Astria Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$19.40
DETAILS
HIGH:
$26.00
LOW:
$13.00
MEDIAN:
$20.00
CONSENSUS:
$19.40
UPSIDE:
54.21%
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.4 | 0.2 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0.5 | (0.4) | (0.2) | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 77.1 | 57.3 | 34.3 | 15.6 | 25.6 | 18.3 | 17.0 | 18.7 | 25.4 | 23.0 | 15.7 | 14.0 | 0.0 |
| SG&A Expenses | 35.3 | 25.7 | 19.7 | 14.8 | 11.8 | 9.1 | 9.3 | 8.9 | 10.1 | 8.6 | 6.0 | 4.1 | 0.0 |
| Other Expenses | (0.8) | 0 | (0.5) | 164.6 | 0 | (0.3) | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0 |
| Operating Expenses | 111.6 | 83.0 | 53.5 | 195.0 | 37.4 | 27.1 | 26.4 | 27.6 | 35.6 | 31.7 | 21.7 | 18.1 | 0.0 |
| Operating Income | |||||||||||||
| Operating Income | (111.6) | (83.0) | (53.5) | (195.0) | (37.4) | (27.1) | (26.4) | (27.1) | (35.6) | (31.7) | (21.7) | (18.1) | (0.0) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.5 | 0.8 | 1.0 | 0.2 | 0 | 0 |
| Interest Income | 17.4 | 10.2 | 1.7 | 0.1 | 0.2 | 0.8 | 0.4 | 0.2 | 0.2 | 0 | 0 | 0 | 0.0 |
| Profitability | |||||||||||||
| EBITDA | (111.6) | (83.0) | (53.5) | (30.4) | (37.4) | (27.1) | (25.7) | (26.6) | (34.8) | (31.5) | (21.4) | (17.8) | (15.3) |
| EBIT | (111.6) | (67.8) | (53.5) | (30.4) | (37.4) | (27.1) | (25.8) | (26.9) | (35.2) | (31.7) | (21.7) | (18.1) | (15.7) |
| Income Before Tax | (94.3) | (72.9) | (51.8) | (194.9) | (37.3) | (26.3) | (25.9) | (27.4) | (36.1) | (32.6) | (21.9) | (18.1) | (0.0) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 |
| Net Income | (94.3) | (72.9) | (51.8) | (194.9) | (37.3) | (26.3) | (25.9) | (27.4) | (36.1) | (32.6) | (21.9) | (18.1) | (0.0) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 | -125.45 | -0.11 |
| EPS (Diluted) | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 | -125.45 | -0.11 |
| Shares Outstanding | 56.2 | 30.1 | 14.6 | 8.9 | 3.1 | 1.9 | 0.8 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 59.8 | 175.5 | 20.5 | 86.5 | 24.9 | 9.9 | 15.3 | 16.4 | 23.6 | 62.8 |
| Short-Term Investments | 268.3 | 71 | 205.9 | 39 | 20 | 26.3 | 22.3 | 0 | 14.9 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 6.5 | 4.4 | 1.3 | 0 | 0 | 0 | 0 | 1.1 | 1.0 | 0 |
| Total Current Assets | 334.6 | 250.9 | 227.7 | 127.1 | 46.3 | 39.0 | 38.9 | 17.5 | 39.5 | 63.6 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 5.1 | 0.4 | 0.9 | 0.4 | 1.0 | 2.3 | 0.1 | 0.3 | 0.6 | 0.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.1 |
| Other Non-Current Assets | 2.6 | 3.4 | 2.0 | 0.0 | 0.2 | 0.5 | 0.2 | 0 | 0 | 0.0 |
| Total Non-Current Assets | 7.7 | 3.7 | 2.9 | 0.4 | 1.1 | 2.8 | 0.3 | 0.4 | 0.7 | 0.6 |
| Total Assets | 342.4 | 254.7 | 230.6 | 127.5 | 47.5 | 41.8 | 39.2 | 17.9 | 40.2 | 64.2 |
| Current Liabilities | ||||||||||
| Account Payables | 4.3 | 1.5 | 0.8 | 1.6 | 1.5 | 1.2 | 1.4 | 0.8 | 1.4 | 1.3 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.5 | 3.2 | 3.2 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.4 | 0 | 0 |
| Other Current Liabilities | 0 | 4.0 | 3.4 | 2.0 | 2.1 | 1.4 | 1.5 | 0.3 | 0 | 0 |
| Total Current Liabilities | 19.1 | 11.6 | 9.1 | 5.2 | 6.4 | 5.0 | 4.2 | 6.0 | 8.3 | 7.8 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.5 | 5.7 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.3 | 0.2 |
| Total Non-Current Liabilities | 4.0 | 0 | 0.4 | 0 | 0.4 | 1.0 | 0.1 | 0.1 | 2.8 | 5.9 |
| Total Liabilities | 23.1 | 11.6 | 9.4 | 5.2 | 6.8 | 6.1 | 4.2 | 6.1 | 11.1 | 13.7 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (674.8) | (580.5) | (507.6) | (455.8) | (260.9) | (223.6) | (197.3) | (171.4) | (144.1) | (108.0) |
| Accumulated Other Comprehensive Income | 0.2 | 0 | (0.1) | 0 | 0 | 0 | (0.0) | 0 | (0.0) | (64.2) |
| Total Stockholders' Equity | 319.3 | 243.1 | 221.2 | 122.3 | 40.7 | 35.7 | 34.9 | 11.8 | 29.1 | 50.5 |
| Total Liabilities & Equity | 342.4 | 254.7 | 230.6 | 127.5 | 47.5 | 41.8 | 39.2 | 17.9 | 40.2 | 64.2 |
| Debt Metrics | ||||||||||
| Total Debt | 5.4 | 0.3 | 0.9 | 0.4 | 1.0 | 2.3 | 0 | 2.5 | 5.7 | 8.9 |
| Net Debt | (54.5) | (175.2) | (19.6) | (86.1) | (23.9) | (7.6) | (15.3) | (13.9) | (17.9) | (53.8) |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (94.3) | (72.9) | (51.8) | (194.9) | (37.3) | (26.3) | (25.9) | (27.4) | (36.1) | (32.6) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.1 | 0.3 | 0.4 | 0.2 |
| Stock-Based Compensation | 13.0 | 6.3 | 4.6 | 3.4 | 1.4 | 1.5 | 1.8 | 2.0 | 2.2 | 1.7 |
| Change in Working Capital | 4.5 | (2.4) | 2.6 | (3.3) | 3.4 | (1.9) | 0.8 | (1.9) | 0.3 | 0.7 |
| Other Non-Cash Items | (4.5) | 0.5 | 1.1 | 164.7 | 0.1 | 0.0 | 0.1 | 0.2 | 0.3 | 0.3 |
| Operating Cash Flow | (81.2) | (68.4) | (43.5) | (30.2) | (32.5) | (26.6) | (23.5) | (26.8) | (32.9) | (29.8) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.3) | (0.0) | (0.1) | (0.0) | (0.0) | (0.0) | 0.0 | (0.1) | (0.5) | (0.4) |
| Acquisitions | 0 | 0 | 0.2 | 6.5 | (0.0) | 0.0 | (0.0) | 45.5 | 0.1 | 0 |
| Purchases of Investments | (4,244.5) | (1,924.4) | (396.1) | (78) | (62.8) | (155.2) | (70.4) | (45.5) | (45.5) | 0 |
| Sales/Maturities of Investments | 4,053 | 2,059.5 | 229.0 | 59 | 69.1 | 151.1 | 48.1 | 14.9 | 30.5 | 0 |
| Other Investing Activities | 0 | 0 | (0.2) | 0 | 0.0 | (0.0) | 0.4 | 0.0 | 0.1 | 0 |
| Investing Cash Flow | (191.9) | 135.1 | (167.1) | (12.6) | 6.3 | (4.1) | (21.9) | 14.9 | (15.5) | (0.4) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | (2.8) | (3.3) | (3.3) | 4.2 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.8 | 0.4 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.5 | 0.1 |
| Financing Cash Flow | 157.2 | 88.4 | 144.7 | 104.3 | 40.9 | 25.6 | 44.3 | 4.7 | 9.2 | 78.3 |
| Cash Position | ||||||||||
| Net Change in Cash | (115.9) | 155.0 | (65.9) | 61.6 | 14.7 | (5.0) | (1.1) | (7.2) | (39.2) | 48.1 |
| Cash at Beginning | 175.7 | 20.7 | 86.6 | 25.1 | 10.4 | 15.4 | 16.5 | 23.6 | 62.8 | 14.7 |
| Cash at End | 59.8 | 175.7 | 20.7 | 86.6 | 25.1 | 10.4 | 15.4 | 16.4 | 23.6 | 62.8 |
| Free Cash Flow | (81.5) | (68.5) | (43.6) | (30.2) | (32.5) | (26.6) | (23.4) | (26.9) | (33.3) | (30.2) |
| Key Metrics | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0.5 | (0.4) | (0.2) | 0 | 0 | 0 |
| Operating Income | (111.6) | (83.0) | (53.5) | (195.0) | (37.4) | (27.1) | (26.4) | (27.1) | (35.6) | (31.7) | (21.7) | (18.1) | (0.0) |
| Net Income | (94.3) | (72.9) | (51.8) | (194.9) | (37.3) | (26.3) | (25.9) | (27.4) | (36.1) | (32.6) | (21.9) | (18.1) | (0.0) |
| EPS (Diluted) | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 | -125.45 | -0.11 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 59.8 | 175.5 | 20.5 | 86.5 | 24.9 | 9.9 | 15.3 | 16.4 | 23.6 | 62.8 | |||
| Total Assets | 342.4 | 254.7 | 230.6 | 127.5 | 47.5 | 41.8 | 39.2 | 17.9 | 40.2 | 64.2 | |||
| Total Debt | 5.4 | 0.3 | 0.9 | 0.4 | 1.0 | 2.3 | 0 | 2.5 | 5.7 | 8.9 | |||
| Stockholders' Equity | 319.3 | 243.1 | 221.2 | 122.3 | 40.7 | 35.7 | 34.9 | 11.8 | 29.1 | 50.5 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (81.2) | (68.4) | (43.5) | (30.2) | (32.5) | (26.6) | (23.5) | (26.8) | (32.9) | (29.8) | |||
| Capital Expenditure | (0.3) | (0.0) | (0.1) | (0.0) | (0.0) | (0.0) | 0.0 | (0.1) | (0.5) | (0.4) | |||
| Free Cash Flow | (81.5) | (68.5) | (43.6) | (30.2) | (32.5) | (26.6) | (23.4) | (26.9) | (33.3) | (30.2) | |||